Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Dermata Therapeutics, Inc. (DRMA) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.69M |
|
-- |
|
-- |
|
$1.76M |
|
$-1.76M |
|
$0.07M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.76M |
|
$-1.76M |
|
1.03M |
|
1.03M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$5.07M |
|
-- |
|
-- |
|
$5.07M |
|
$1.11M |
|
-- |
|
-- |
|
$1.11M |
|
$3.96M |
|
$3.96M |
|
$3.96M |
|
0.84M |
|
| Cash Flow Statement Financials | |
$-6.43M |
|
-- |
|
$7.93M |
|
$3.16M |
|
$4.66M |
|
$1.50M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.56 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.73% |
|
-42.73% |
|
-33.36% |
|
-42.73% |
|
$4.69 |
|
$-6.26 |
|
$-6.26 |
|